Potential of neutrophil-to-eosinophil ratio as a new prognostic tool for patients with advanced renal cell carcinoma receiving first-line immuno-oncology combinations
Saved in:
Main Authors: | Daniel Y C Heng, Kosuke Takemura |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-12-01
|
Series: | BMJ Oncology |
Online Access: | https://bmjoncology.bmj.com/content/3/1/e000481.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leveraging mRNA technology for antigen based immuno-oncology therapies
by: Wei Zheng, et al.
Published: (2025-01-01) -
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases
by: Wei Wei, et al.
Published: (2023-08-01) -
Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023
by: Siqi Zhang, et al.
Published: (2025-12-01) -
Next-generation ctDNA-driven clinical trials in precision immuno-oncology
by: Charu Aggarwal, et al.
Published: (2023-01-01) -
The prognostic value of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer
by: Mustafa Kandaz, et al.
Published: (2025-01-01)